569
Views
21
CrossRef citations to date
0
Altmetric
Review Article

Psychiatric and psychosocial challenges in patients undergoing haematopoietic stem cell transplants

&
Pages 74-86 | Received 11 Sep 2013, Accepted 10 Nov 2013, Published online: 25 Feb 2014

References

  • Acharya, S. & Bussel, J.B. (2000). Hematologic toxicity of sodium valproate. Journal of Pediatric Hematology-Oncology, 22, 62–65.
  • Ahmed, A. (2002). Neutropenia associated with mirtazapine use: Is a drop in the neutrophil count in a symptomatic older adult a cause for concern. Journal of the American Geriatric Society, 50, 1461–1463.
  • Andrykowski, M.A., Bishop, M.M., Hahn, E.A., Cella, D.F., Beaumont, J.L., Brady, M.J., Horowitz, M.M., Sobocinski, K.A., Rizzo, J.D. & Wingard, J.R. (2005). Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 23, 599–608.
  • Beattie, S. & Lebel, S. (2011). The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: A comprehensive literature review. Psycho-Oncology, 20, 1137–1150.
  • Beglinger, L.J., Duff, K., Van Der Heiden, S., Parrott, K., Langbehn, D. & Gingrich, R. (2006). Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients. Biol Blood Marrow Transplant, 12, 928–935.
  • Bevans, M. (2010). Health-related quality of life following allogeneic hematopoietic stem cell transplantation. Hematology, 248–254.
  • Bevans, M.F., Marden, S., Leidy, N.K., Soeken, K., Cusack, G., Rivera, P., … Barrett, A.J. (2006). Health- related quality of life in patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantations. Bone Marrow Transplantation, 38, 101–109.
  • Bevans, M.F., Mitchell, S.A. & Marden, S. (2008). The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Supportive Care in Cancer, 16, 1243–1254.
  • Bishop, M.M., Beaumont, J.L., Hahn, E.A., Cella, D., Andrykowski, M.A., Brady, M.J., … Wingard, J.R. (2007). Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. Journal of Clinical Oncology, 25, 1403–1411.
  • Blackburn, S.C., Oliart, A.D., García Rodríguez, L.A. & Perez Gutthann, S. (1998). Antiepileptics and blood dyscrasias: A cohort study. Pharmacotherapy, 18, 1277–1283.
  • Blumenthal, J.A., Lett, H.D., Babyak, M.A., Smith, P.K., Mark, D.B., Jones, R., … NORG Investigators. (2003). Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet, 362, 604–609.
  • Bovbjerg, D.H. & Valdimarsdottir, H.B. (1998). Psychoneuroimmunology: Implications for psycho-oncology. In Holland, J.C., Breitbart, W.S., Jacobsen, P.B., Lederberg, M.S. & Loscalzo, M.J. (Eds.). Psycho-Oncology. New York: Oxford University Press, 125–134.
  • Breitbart, W. & Alici, Y. (2012). Evidence-based treatment of delirium in patients with cancer. Journal of Clinical Oncology, 30, 1206–1214.
  • Breitbart, W., Marotta R., Platt, M.M., Weisman, H., Derevenco, M., Grau, C., … Jacobson, P. (1996). A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. American Journal of Psychiatry, 153, 231–237.
  • Brouwers, P., Riccardi, R., Fedio, P. & Poplack, D.G. (1985). Long-term neuropsychologic sequelae of childhood leukemia: Correlation with CT brain scan abnormalities. Journal of Pediatrics, 106, 723–728.
  • Bush, N.E., Donaldson, G.W., Haberman, M.H., Dacanay, R. & Sullivan, K.M. (2000). Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: A longitudinal follow-up of 415 patients. Biology of Blood and Marrow Transplantation, 6, 576–591.
  • Chang, G., Orav, E.J., McNamara, T.K., Tong, M.Y. & Antin, J.H. (2005). Psychosocial function after hematopoietic stem cell transplantation. Psychosomatics, 46, 34–40.
  • Civalier, K.A., Krahn, L.E. & Agrwal, N. (2009). Repeated episodes of neutropenia triggered by mirtazapine. Psychosomatics, 50, 299–300.
  • Cook, L., Grant, M. & Gemmill, R. (2012). Discharge needs of allogeneic transplant recipients. Clinical Journal of Oncology Nursing, 16, 142–149.
  • Couriel, D., Carpenter, P.A., Cutler, C., Bolaños-Meade, J, … Flowers, M.E. (2006). Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation, 12, 375–396.
  • DiMatteo, M.R., Lepper, H.S. & Croghan, T.W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101–2107.
  • Duggal, H.S., & Singh, I. (2005). Psychotropic drug-induced neutropenia. Drugs Today (Barc), 41, 517–526. Review.
  • DuHamel, K.N., Mosher, C.E., Wonkel, G., Labay, L.E., Rini, C., … Lawsin, C.R. (2010). Randomized clinical trial of telephone-administered cognitive behavioral therapy to reduce posttraumatic stress disorder and distress symptoms after hematopoietic stem cell transplantation. Journal of Clinical Oncology, 28, 3754–3761.
  • DuHamel, K.N., Ostrof, J., Ashman, T., Winkel, G., Mundy, E.A., … Redd, W. (2004). Construct validity of the posttraumatic stress disorder checklist in cancer survivors: Analyses based on two samples. Psychological Assessment, 16, 255–266.
  • DuHamel, K.N., Smith, M.Y., Vickberg, S.M., Papadouplolous, E., Ostroff, J., … Redd, W.H. (2001). Trauma symptoms in bone marrow transplant survivors: The role of nonmedical life events. Journal of Traumatic Stress, 14, 95–113.
  • El-Banna, M.M., Berger, A.M., Farr, L., Foxall, M.J. & Schreiner, E. (2004). Fatigue and depression in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation. Oncology Nursing Forum, 31, 937–944.
  • Eldredge, D.H., Nail, L.M., Maziarz, R.T., Hansen, L.K., Ewing, D. & ArchBold, P.G. (2006). Explaining family caregiver role strain following autologous blood and marrow transplantation. Journal of Psychosomatic Oncology, 24, 53–74.
  • Fann, J.R., Roth-Roemer, S., Burington, B.E., Katon, W.J. & Syrjala, K.L. (2002). Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer, 95, 1971–1981.
  • Fife, B.L., Huster, G.A., Cornetta, K.G., Kennedy, V.N., Akard, L.P. & Braun, R. (2000). Longitudinal study of adaptation to the stress of bone marrow transplantation. Journal of Clinical Oncology, 18, 1539–1549.
  • Fife, B., Monchan, P., Abonour, R., Wood, L. & Stump, T. (2009). Adaptation of family caregivers during the acute phase of adult BMT. Bone Marrow Transplantation, 43, 959–966.
  • Foster, L.W., McLellan, L.J., Rybicki, L.A., Dabney, J., Welsh, E. & Bolwell, B.J. (2006). Allogeneic BMT and patient eligibility based on psychosocial criteria: A survey of BMT professionals. Bone Marrow Transplantation, 37, 223–228.
  • Foster, L.W., McLellan, L., Rybicki, L., Dabney, J., Visnosky, M. & Bolwell, B. (2009). Utility of the psychosocial assessment of candidates for transplantation (PACT) scale in allogeneic BMT. Bone Marrow Transplantation, 44, 375–380.
  • Fraser, C.J., Bhatia, S., Ness, K., Carter, A., Francisco, L., Arora, M., … Baker, K.S. (2006). Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: A report from the Bone Marrow Transplant Survivor Study. Blood, 108, 2867–2873.
  • Frick, E., Rieg-Appleson, C., Tyroller, M. & Bumeder, I. (2005). Social support, affectivity, and the quality of life of patients and their support-givers prior to stem cell transplantation. Journal of Psychosocial Oncology, 23, 15–34.
  • Gielissen, M.F.M., Schattenberg, A.V.M., Verhagen, C., Rinken, M.J., Bremmers, M.E.J. & Bleijenberg, G. (2007). Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplantation, 39, 595–603.
  • Grant, M., Cooke, L., Williams, A.M., Bhatia, S., Popplewell, L., Uman, G. & Forman, S.E. (2012). Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: A comparison of sociodemographic, disease, and treatment characteristics. Supportive Care in Cancer, 20, 2697–2704.
  • Gratwohl, A., Baldomero, H., Aljurf, M, Pasquini, M.C., Bouzas, L.F., Yoshimi, A. … Worldwide Network of Blood and Marrow Transplantation. (2010). Hematopoietic stem cell transplantation: A global perspective. Journal of the American Medical Association, 303, 1617–1624.
  • Grulke, N., Larbig, W., Kachele, H. & Bailer, H. (2008). Pre-transplant depression as risk factor for survival of patients undergoing allogeneic hematopoietic stem cell transplantation. Psycho-Oncology, 17, 480–487.
  • Gulbrandsen, N., Hjermstad, M.J. & Wisloff, F. (2004). Nordic Myeloma Study Group. Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. European Journal of Haematology, 72, 172–180.
  • Gureje, O., Vonkorff, M., Simon, G.E. & Gater, R. (1998). Persistent pain and well-being: A World Health Organization study in primary care. Journal of the American Medical Association, 280, 147–151.
  • Hall, R.L., Smith, A.G. & Edwards, J.G. (2003). Haematological safety of antipsychotic drugs. Expert Opinion on Drug Safety, 2, 395–399.
  • Halperin, D. & Reber, G. (2007). Influence of antidepressants on hemostasis. Dialogues in Clinical Neuroscience, 9, 47–59.
  • Harder, H., Cornelissen, J.J., Van Gool, A.R., Duivenvoorden, H.J., Eijkenboom, W.M. & Van den Bent, M.J. (2002). Cognitive functioning and quality of life in long- term adult survivors of bone marrow transplantation. Cancer, 95, 183–192.
  • Harper, A., Power, M. & Orley, J. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological Medicine, 28, 551–558.
  • Hartmann, P.M. (1999). Mirtazapine: A newer antidepressant. American Family Physician, 59, 159–161.
  • Hendriks, M.G.J. & Schoiten, H.C. (2002). Quality of life after stem cell transplantation: A patient, partner and physician perspective. European Journal of Internal Medicine, 13, 52–56.
  • Hjermstad, M.J., Evensen, S.A., Kvaløy, S.O., Fayers, P.M. & Kaasa, S. (1999a). Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: A prospective study. Journal of Clinical Oncology, 17, 706–718.
  • Hjermstad, M.J., Knobel, H., Brinch, L., Fayers, P.M., Loge, J.H., Holte, H. & Kaasa, S. (2004). A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplantation, 34, 257–266.
  • Hjermstad, M.J., Loge, J.H., Evensen, S.A., Kvaløy, S.O., Fayers, P.M. & Kaasa, S. (1999b). The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplantion, 24, 1219–1228.
  • Hoodin, F. & Weber, S. (2003). A systematic review of psychosocial factors affecting survival after bone marrow transplantation. Psychosomatics, 44, 181–195.
  • Hoodin, F., Uberti, J.P., Lynch, T.J., Steele, P. & Ratanatharathorn, V. (2006). Do negative or positive emotions differentially impact mortality after adult stem cell transplant?Bone Marrow Transplantation, 38, 255–264.
  • Horowitz, M.M. (2012). Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients?Best Practice and Research: Clinical Haematology, 25, 483–486.
  • Horwitz, M.E. & Sullivan, K.M. (2006). Chronic graft- versus-host disease. Blood Reviews, 20, 15–27.
  • Huynh, M., Chee, K. & Lau, D.H. (2005). Thrombotic thrombocytopenic purpura associated with quetiapine. Annals of Pharmacotherapy, 39, 1346–1348.
  • Ickovicks, J.R., Hamburger, M.E., Vlahov, D., Schoenbaum, E.E., Schuman, P., Boland, R.J. & Moore, J. (2001). Mortality, CD4 count decline and depressive symptoms among HIV seropositive women: Longitudinal analysis from the HIV epidemiology research study. Journal of the American Medical Association, 285, 1466–1474.
  • Jacobs, S.R., Small, B.J., Booth-Jones, M., Jacobsen, P.B. & Fields, K.K. (2007). Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. Cancer, 110, 1560–1567.
  • Jacobsen, P.B., Sadler, I.J., Booth-Jones, M., Soety, E., Weitzner, M.A. & Fields, K.K. (2002). Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for cancer. Journal of Consulting Clinical Psychology, 70, 235–240.
  • Jenks Kettmann, J.D. & Altmaier, E.M. (2008). Social support and depression among bone marrow transplant patients. Journal of Health Psychology, 13, 39–46.
  • Kiecolt-Glaser, J.K. & Glaser, R. (2002). Depression and immune function: Central pathways to morbidity and mortality. Journal of Psychosomatic Research, 53, 873–876.
  • Kiss, T.L., Abdolell, M., Jamal, N., Minden, M.D., Lipton, J.H. & Messner, H.A. (2002). Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 20, 2334–2343.
  • Kroenkers, K., Spitzer, R.L., Williams, J.B., Linzer, M., Hahn, S.R., de Gruy, F.V. III & Brody, D. (1994). Physical symptoms in primary care: Predictors of psychiatric disorders and functional impairment. Archives of Family Medicine, 3, 774–779.
  • Langer, S.L., Abrams, J.R., Storer, B., Sanders, J.E., Flowers, M.E. & Martin, P.J. (2004). Recovery and long- term function after hematopoietic cell transplantation for leukemia or lymphoma. Journal of the American Medical Association, 291, 2335–2343.
  • Langer, S., Abrams, J. & Syrjala, K. (2003). Caregiver and patient marital satisfaction and affect following hematopoietic stem cell transplantation: A prospective, longitudinal investigation. Psycho-Oncology, 12, 239–253.
  • Larsen, J., Nordstrom, G., Ljungman, P. & Gardulf, A. (2004). Symptom occurrence, symptom intensity and symptom distress in patients undergoing high-dose chemotherapy with stem cell transplantation. Cancer Nursing, 27, 55–64.
  • Le, R.Q., Bevans, M., Savani, B.N., Mitchell, S.A., Stringaris, K., Koklanaris, E. & Barrett, A.J. (2010). Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biology of Blood and Marrow Transplantation, 16, 1162–1170.
  • Lee, S.J., Fairclough, D., Parsons, S.K., Soiffer, R.J., Fisher, D.C., Schlossman, R.L., Antin, J.H. & Weeks, J.C. (2001). Recovery after stem-cell transplantation for hematologic diseases. Journal of Clinical Oncology, 19, 242–252.
  • Lee, S.J., Kim, H.T., Ho, V.T., Cutler, C., Alyea, E.P., Soiffer, R.J. & Antin, J.H. (2006). Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplantation, 38, 305–310.
  • Lee, S.J., Loberiza, F.R., Antin, J.H., Kirkpatrick, T., Prokop, L., Alyea, E.P. & Soiffer, R.J. (2005). Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplantation, 35, 77–83.
  • Lesperance, F., Frasure-Smith, N., Talajic, M. & Bourassa, M.G. (2002). Five year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myorcardial infarction. Circulation, 105, 1049–1053.
  • Loberiza, F.R., Jr, Rizzo, J.D., Bredeson, C.N., Antin, J.H., Horowitz, M.M., Weeks, J.C. & Lee, S.J. (2002). Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. Journal of Clinical Oncology, 20, 2118–2126.
  • Lonergan, E., Britton, A.M., Luxenberg, J. & Wyller, T. (2007). Antipsychotics for delirium. Cochrane Database of Systematic Reviews, 2, CD005594.
  • Martin, K.A., Krahn, L.E., Balan, V. & Rosati, M.J. (2007). Selective serotonin reuptake inhibitors in the context of hepatitis C infection: Reexamining the risks of bleeding. Journal of Clinical Psychiatry, 68, 1024–1026.
  • McQuellon, R.P., Russell, G.B., Rambo, T.D., Craven, B.L., Radford, J., Perry, J.J., Cruz, J. & Hurd, D.D. (1998). Quality of life and psychological distress of bone marrow transplant recipients: The time trajectory to recover over the first year. Bone Marrow Transplantation, 21, 477–486.
  • Meyers, C.A., Weitzner, M., Byrne, K., Valentine, A., Champlin, R.E. & Przepiorka, D. (1994). Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. Journal of Clinical Oncology, 12, 820–826.
  • Molassiotis, A., van den Akker, O.B. & Boughton, B.J. (1997). Perceived social support, family environment and psychosocial recovery in bone marrow transplant long-term survivors. Social Science and Medicine, 44, 317–325.
  • Molassiotis, A., Wilson, B., Blair, S., Howe, T. & Cavet, J. (2011). Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology, 20, 88–97.
  • Mosher, C.E., Redd, W.H., Rini, C.M., Burkhalter, J.E. & DuHamel, KN. (2009). Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho-Oncology, 18, 113–27.
  • Mosher, C.E., DuHamel, K., Rini, C., Corner, G., Lam, J. & Redd, W. (2011). Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Supportive Care in Cancer, 19, 1357–1365.
  • Oyesanmi, O., Kunkel, E.J., Monti, D.A. & Field, H.L. (1999). Hematologic side effects of psychotropics. Psychosomatics, 40, 414–421.
  • Ozdemir, M.A., Sofuoglu, S., Tanrikulu, G., Aldanmaz, F., Esel, E. & Dundar, S. (1994). Lithium-induced hematologic changes in patients with bipolar affective disorder. Biological Psychiatry, 35, 210–213.
  • Pasquini, M.C. & Wang, Z. (2011). Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides. Center for International Blood and Marrow Transplant Research. Retrieved from http://www.cibmtr.org
  • Perucca, E. (2002). Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience. CNS Drugs, 16, 695–714.
  • Pidala, J., Anasetti, C. & Jim, H. (2009). Quality of life after allogeneic hematopoietic cell transplantation. Blood, 114, 7–19.
  • Prieto, J.M., Blanch, J., Atala, J., Carreras, E., Rovira, M., Cirera, E. & Casto, C. (2002). Psychiatric morbidity and impact on hospital length of stay among hematological cancer patients receiving stem cell transplantation. Journal of Clinical Oncology, 20, 1907–1917.
  • Prieto J.M., Atala J., Blanch J., Carreras E., Rovira M., Cirera E., Espinal A. & Gasto C. (2005). Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. Journal of Clinical Oncology, 23, 6063–6071.
  • Reeves, R.R., Wise, P.M. & Cox, S.K. (2007). SSRIs & the risk of abnormal bleeding. Journal of Psychosocial Nursing Mental Health Services, 45, 15–21.
  • Romanowicz, M., Ehlers, S., Walker, D., Decker, P., Rundell, J., Shinozaki, G., … Black, J. (2012). Testing a diathesis-stress model: Potential genetic risk factors for development of distress in context of acute leukemia diagnosis and transplant. Psychosomatics, 54, 456–462.
  • Sabo, B., McLeod, D. & Couban, S. (2013). The experience of caring for a spouse undergoing a stem cell transplantation: Opening Pandora's box. Cancer Nursing, 36, 29–40.
  • Sasaki, T., Akaho, R., Sakamaki, H., Yoshino, M., Hagiya, K. & Atsumi, M. (2000). Mental disturbances during isolation in bone marrow transplant patients with leukemia. Bone Marrow Transplantation, 25, 315–318.
  • Schwartzberg, L.S. (2006). Neutropenia: Etiology and pathogenesis. Clinical Cornerstone, 8(Suppl.5), S5–11.
  • Serebruany, V.L. (2006). Selective serotonin reuptake inhibitors and increased bleeding risk: Are we missing something?American Journal of Medicine, 119, 113–116.
  • Sherman, A.C., Simonton, S., Latif, U., Spohn, R. & Tricot, G. (2004). Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplantation, 33, 955–962.
  • Schultz-Kaderman, F., Mehnert, A., Scherwath, A., Schirmer, L., Schleimer, B., Zander, A.R. & Koch, U. (2007). Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. Bone Marrow Transplantation, 39, 789–799.
  • Simon, G.E., Vonkorff, M., Piccinelli, M., Fullerton, C. & Ormel, J. (1999). An international study of the relation between somatic symptoms and depression. New England Journal of Medicine, 341, 1329–1335.
  • Sostak, P., Padovan, C.S., Yousry, T.A., Ledderose, G., Kolb, H.J. & Straube, A. (2003). Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology, 60, 842–848.
  • Spiegel, D. & Giese-Davis, J. (2003). Depression and cancer: Mechanisms and disease progression. Biological Psychiatry, 54, 269–282.
  • Sun, C., Liton, F., Baker, K.S., Weisdorf, D.J., Forman, S.J. & Bhatia, S. (2011). Adverse psychological outcomes in long-term survivors of hematopoietic stem cell transplantations: A report from the bone marrow transplant survivor study (BMTSS). Blood, 118, 4723–4731.
  • Syrjala K.L., Artherholt, S.B., Kurland, B.F., Langer, S.L., Roth-Roemer, S., Elrod, J.B. & Dikmen, S. (2011). Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. Journal of Clinical Oncology, 29, 2397–2404.
  • Syrjala, K.L. & Chapko, M.E. (1995). Evidence for a biopsychosocial model of cancer treatment-related pain. Pain, 61, 69–79.
  • Syrjala, K.L., Chapko, M.K., Vitaliano, P.P., Cummings, C. & Sullivan, K.M. (1993). Recovery after allogeneic marrow transplantation: Prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplantation, 11, 319–327.
  • Syrjala, K.L., Langer, S.L., Abrams, J.R., Storer, B., Sanders, J.E., Flowers, M.E. & Martin, P.J. (2004a). Recovery and long term function after hematopoietic cell transplantation for leukemia or lymphoma. Journal of the American Medical Association, 291, 2335–2343. doi:10.1001/jama.291.19.2335
  • Syrjala, K.L., Stover, A.C., Yi, J.C., Artherholt, S.B. & Abrams, J.R. (2010). Measuring social activities and social function in long-term cancer survivors who received hematopoietic stem cell transplantation. Psycho-Oncology, 19, 462–71.
  • Teno, J.M., Harrell, F.E. Jr, Knaus, W., Phillips, R.S., Wu, A.W., Connors, A. Jr, .. Lynn, J. (2000). Prediction of survival for older hospitalized patients: The HELP survival model. Hospitalized Elderly Longitudinal Project. Journal of the American Geriatric Society, 48(Suppl.5), S16–S24.
  • Tross, S., Herndon, J. II, Korzun, A., Kornblith, A.B., Cella, D.F., Holland, J.F., … Holland, J.C. (1998). Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. Journal of the National Cancer Institute, 88, 661–667.
  • Weckmann, M.T., Gingrich, R., Mills, J.A., Hook, L. & Beglinger, L.J. (2012). Risk factors for delirium in patients undergoing hematopoietic stem cell transplantation. Annals of Clinical Psychiatry, 24, 204–214.
  • Wells, K.J., Booth-Jones, M. & Jacobsen, P.B. (2009). Do coping and social support predict depression and anxiety in patients undergoing hematopoietic stem cell transplantation?Journal of Psychosocial Oncology, 27, 297–315.
  • Wessinger, S., Kaplan, M., Choi, L., Williams, M., Lau, C., Sharp, L. & Jones, M.P. (2006). Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: A multicentre retrospective analysis. Alimentary Pharmacology and Therapeutics, 23, 937–944.
  • Wettergren, L., Langius, A., Björkholm, M. & Björvell, H. (1999). Post-traumatic stress symptoms in patients undergoing autologous stem cell transplantation. Acta Oncologica, 38, 475–480.
  • Widows, M.R., Jacobsen, P.B. & Fields, K.K. (2000). Relation of psychological vulnerability factors to posttraumatic stress disorder symptomatology in bone marrow transplant recipients. Psychosomatic Medicine, 62, 873–882.
  • Wong, R., Giralt, S.A., Martin, T., Couriel, D.R., Anagnostopoulos, A., Hosing, C., Andersson, B.S., Cano, P., Shahjahan, M., Ippoliti, C., Estey, E.H., McMannis, J., Gajewski, J.L., Champlin, R.E. & de Lima M. (2003). Reduced Intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55. Blood, 102, 3052–3059.
  • Wong, F.L., Liton, F., Togawa, K., Bosworth, A., Glonzalez, M., Hanby, C., … Bhatia, S. (2010). Long-term recovery after hematopoietic cell transplantation: Predictors of quality of life concerns. Blood, 115, 2508–2519.
  • Worel, N., Biener, D., Kalhs, P., Mitterbauer, M., Keil, F., Schulenburg, A., .. Greinix, H.T. (2002). Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplantation, 30, 619–626.
  • Wulsin, L.R., Valliant, G.E. & Wells, V.E. (1999). A systematic review of the mortality of depression. Psychosomatic Medicine, 61, 6–17.
  • Zonderman, A.B., Costa, P.T. Jr & McCrae, R.R. (1989). Depression as a risk for cancer morbidity and mortality in a nationally representative sample. Journal of the American Medical Association, 262, 1191–1195.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.